Digital therapeutics for mental health: Is attrition the Achilles heel?

Affiliations

¹ Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, United States.
² Department of Psychiatry, Weill Cornell Medical College, New York, NY, United States.
³ Departments of Psychiatry, Neurology and Biomedical Engineering, Southwestern Medical Center, The University of Texas, Austin, TX, United States.
⁴ Duke Institute for Brain Sciences, Duke University, Durham, NC, United States.

Adaora Nwosu et al. Front Psychiatry. 2022.

. 2022 Aug 5:13:900615.

doi: 10.3389/fpsyt.2022.900615. eCollection 2022.

¹ Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, United States.
² Department of Psychiatry, Weill Cornell Medical College, New York, NY, United States.
³ Departments of Psychiatry, Neurology and Biomedical Engineering, Southwestern Medical Center, The University of Texas, Austin, TX, United States.
⁴ Duke Institute for Brain Sciences, Duke University, Durham, NC, United States.

No abstract available

Keywords: ADHD; Alzheimer's disease; PTSD; addiction; anxiety; autism; depression; schizophrenia.

References

1. Doraiswamy PM, London E, Varnum P, Harvey B, Saxena S, Tottman S, et al. Empowering 8 billion minds: Enabling better mental health for all via the ethical adoption of technologies. NAM Perspect. (2019). 10.31478/201910b. Available online at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406599/ (accessed May 9, 2022). - DOI - PMC - PubMed
1. CB Insights,. State of Mental Health Tech 2021 report. CB Insights Research. (2022). Available online at: https://www.cbinsights.com/research/report/mental-health-tech-trends-2021/ (accessed May 9, 2022).
1. Wehrwein P. Digital therapeutics shaping the future of care. Managed Healthc Exec. (2021) 31.
1. U.S. Food and Drug Administration. Policy for device software functions and mobile medical applications. (2019). Available online at: https://www.fda.gov/media/80958/download (accessed May 9, 2022).
1. Shuren J, Doraiswamy PM. Digital Therapeutics for MCI and Alzheimer's disease: A Regulatory Perspective – Highlights From The Clinical Trials on Alzheimer's Disease conference (CTAD). J Prev Alzheimers Dis. (2022) 9:236. 10.14283/jpad.2022.28 - DOI - PMC - PubMed